Latest News
Sharing Our Progress and Industry Developments
March 2023: Our CSO, Graham Pockley, PhD, is presenting at the 8th Annual Innate Killer Summit in San Diego, USA:
Wednesday March 29, 2023 at 2.00 pm PST: “Following Patient Outcomes with Circulating Cancer Cell Biomarkers to Determine Response & Efficacy”
October 2022: The US Patent and Trademark Office has granted our patent for a simple blood test to detect the presence of cancers and for monitoring therapeutic response:
‘Quantitative assay for heat shock protein 70 (Hsp70) protein in body fluids’ (US 11,460,472).